Clinical Trials
2 trialsNCT03626285 2026-01-02
Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders
OHSU Knight Cancer Institute
Available
NCT01525407 2017-08-17
Donor Atorvastatin Treatment for Preventing Severe Acute Graft-Versus-Host Disease in Patients Undergoing Myeloablative Peripheral Blood Stem Cell Transplantation
Fred Hutchinson Cancer Center
Phase 2 Completed